Fulgent Genetics, Inc.
$497.29M- Market cap
- $547.00M
- Debt
- +$476.00K
- Cash
- −$50.19M
Capital structure 100% equity / 0% debt · EV / Revenue 1.54x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: FLGT stock price at discount vs KRC $19.88 current versus $44.84 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KRC's multiple
Implied fair value · at FLGT's multiple
Snapshot Sep 8, 11:47 AM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FLGT FY 2025 (ended Dec 31, 2025) · KRC FY 2025 (ended Dec 31, 2025).
Trendline
Eight fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / 0% debt · EV / Revenue 1.54x
Capital structure 45% equity / 55% debt · EV / Revenue 8.40x · EV / EBITDA 20.30x
KRC carries the larger enterprise value at $9.35B against $497.29M; FLGT trades on the lower EV / Revenue multiple (1.54x vs 8.40x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FULGENT GENETICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
KILROY REALTY CORP · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.00x
0.97x
Net debt / EBITDA
Leverage against operating earnings
1.15x
11.06x
Cash and equivalents
Liquid reserves on the balance sheet
$50.19M
$179.32M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
FLGT vs NEO
Natera, Inc.
FLGT vs NTRA
Guardant Health, Inc.
FLGT vs GH
EXACT SCIENCES CORP
FLGT vs EXAS
OPKO HEALTH, INC.
FLGT vs OPK
BXP, Inc.
FLGT vs BXP
ALEXANDRIA REAL ESTATE EQUITIES, INC.
FLGT vs ARE
SL GREEN REALTY CORP
FLGT vs SLG
HIGHWOODS PROPERTIES, INC.
FLGT vs HIW
Douglas Emmett Inc
FLGT vs DEI
$476.00K
$5.27B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.